Ascendis Pharma to Report First Quarter 2025 Financial Results and Provide Business Update on May 1, 2025

Core Viewpoint - Ascendis Pharma A/S will report its first quarter 2025 financial results and provide a business update on May 1, 2025, after U.S. market close, followed by a conference call and live webcast [1] Company Overview - Ascendis Pharma is a global biopharmaceutical company focused on its innovative TransCon technology platform to develop new therapies addressing unmet medical needs [3] - The company is headquartered in Copenhagen, Denmark, with additional facilities in Europe and the United States [3] Event Details - The live webcast for the financial results will be accessible through a provided link, and a replay will be available for 30 days post-event [2]